Protalex Inc. - Corporate Presentation in Boston

Financial Advisors, Investment Advisors, Analysts, and Institutional Portfolio Managers are cordially invited to attend a presentation for: Corporate Presentation In Boston
May 23, 2018 - 12:00 PM EDT
Hilton Boston Downtown / Faneuil Hall (Oliver) - 89 Broad Street, Boston, Massachusetts

Protalex, Inc. is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases including rheumatoid arthritis (RA) and Immune Thrombocytopenia (ITP). In the U.S., Protalex has open INDs for the treatment of RA and ITP and in Europe, an open IMPD for ITP. Please visit the Protalex website at www.protalex.com to learn more about Protalex and its lead drug candidate, PRTX-100.